Merck KGaA Launches Fund

Merck KGaA says it has launched a venture capital fund, called Merck Serono Ventures, to invest in emerging biotechnology companies. The fund aims to support biotech startup companies that have the potential to provide innovative products in Merck Serono’s core therapeutic areas such as neurodegenerative diseases, oncology and autoimmune and inflammatory diseases. The fund will invest up to €40 million ($53 million) during the next five...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers